Related Experiment Videos
[Neonatal cardiac transplantation. Long-term results].
L Houyel1, J Petit, J Bruniaux
1Service de chirurgie des cardiopathies congénitales, hôpital Marie-Lannelongue, 133, av. de la Résistance, 92350 Le Plessis-Robinson. houyel@ccml.com
Archives Des Maladies Du Coeur Et Des Vaisseaux
|July 4, 2003
Summary
Cardiac transplantation in neonates with hypoplastic left heart syndrome shows promise but faces long-term challenges. Further advancements in managing chronic rejection are needed to improve outcomes for these young patients.
Area of Science:
- Pediatric Cardiology
- Cardiac Surgery
- Neonatal Medicine
Context:
- Cardiac transplantation has emerged as a viable treatment for complex congenital heart defects.
- Hypoplastic left heart syndrome (HLHS) presents significant challenges in neonatal care.
- Previous work by Bailey since 1985 established cardiac transplantation as an option.
Purpose:
- To evaluate the outcomes of cardiac transplantation in neonates with hypoplastic left heart syndrome or equivalent malformations.
- To assess the long-term survival and quality of life in this patient cohort.
- To identify challenges and limitations of current neonatal cardiac transplant protocols.
Summary:
- Five neonates with HLHS underwent cardiac transplantation between 1993-1998 with no operative mortality.
- Long-term follow-up revealed one death from rejection, one with coronary artery issues, and three with psychomotor abnormalities.
- Patients were managed with cyclosporine without steroids, highlighting immunosuppression strategies.
Impact:
- Neonatal cardiac transplantation for HLHS presents significant long-term complications, including rejection and developmental issues.
- Current outcomes suggest caution in pursuing widespread neonatal transplantation programs.
- The need for novel therapies to combat chronic rejection is emphasized for improved long-term survival.